Regen BioPharma, Inc. (RGBP)

OTCMKTS · Delayed Price · Currency is USD

0.0890

+0.0318 (55.59%)

Jul 18, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2017 - 2019
Regenerative Medical Applications	236.56K	Log In	Log In	Log In	Log In	Upgrade
Regenerative Medical Applications Growth	0%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2017 - 2019
United States	236.56K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	0%	Log In	Log In	Log In	Log In	Upgrade